RareCyte: $20 Million Raised To Expand Orion Spatial Biology Platform
By Amit Chowdhry ● Jul 1, 2024
RareCyte, a life sciences company offering advanced Precision Biology platforms, including instruments, reagents, software, and services, announced the completion of $20 million in funding from new and existing investors. New investor Forest Road has joined existing investors Arboretum Ventures and F-Prime Capital (which co-led the round) and investors HealthQuest Capital, 5AM Ventures, Agilent Technologies, Company founder Ron Seubert, Sheatree capital, and GKCC LLC.